Medical - Healthcare Plans
Compare Stocks
5 / 10Stock Comparison
MOH vs CNC vs ALHC vs UNH vs CVS
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
Medical - Healthcare Plans
MOH vs CNC vs ALHC vs UNH vs CVS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans | Medical - Healthcare Plans |
| Market Cap | $10.01B | $26.15B | $3.74B | $330.28B | $102.56B |
| Revenue (TTM) | $45.08B | $198.10B | $4.26B | $449.71B | $402.07B |
| Net Income (TTM) | $188M | $-6.44B | $20M | $12.04B | $1.77B |
| Gross Margin | 9.6% | 14.9% | 9.0% | 18.8% | 13.8% |
| Operating Margin | 1.2% | -3.7% | 0.8% | 4.2% | 1.2% |
| Forward P/E | 37.3x | 15.7x | 141.3x | 19.9x | 11.3x |
| Total Debt | $3.95B | $18.78B | $338M | $78.39B | $93.59B |
| Cash & Equiv. | $4.25B | $17.89B | $578M | $24.36B | $8.51B |
MOH vs CNC vs ALHC vs UNH vs CVS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Molina Healthcare, … (MOH) | 100 | 82.2 | -17.8% |
| Centene Corporation (CNC) | 100 | 82.9 | -17.1% |
| Alignment Healthcar… (ALHC) | 100 | 83.4 | -16.6% |
| UnitedHealth Group … (UNH) | 100 | 97.8 | -2.2% |
| CVS Health Corporat… (CVS) | 100 | 107.3 | +7.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MOH vs CNC vs ALHC vs UNH vs CVS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, MOH doesn't own a clear edge in any measured category.
CNC ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.39, Low D/E 93.6%, current ratio 1.68x
- Lower P/E (15.7x vs 19.9x)
ALHC is the clearest fit if your priority is growth exposure.
- Rev growth 46.1%, EPS growth 99.4%, 3Y rev CAGR 40.2%
- 46.1% revenue growth vs CVS's 7.8%
UNH carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 217.0% 10Y total return vs MOH's 323.6%
- Combined ratio 1.0 vs CNC's 1.0 (lower = better underwriting)
- 2.4% yield, 25-year raise streak, vs CVS's 3.3%, (3 stocks pay no dividend)
- 3.9% ROA vs CNC's -7.9%, ROIC 9.2% vs -21.6%
CVS is the #2 pick in this set and the best alternative if income & stability and defensive is your priority.
- Dividend streak 0 yrs, beta 0.05, yield 3.3%
- Beta 0.05, yield 3.3%, current ratio 0.84x
- Beta 0.05 vs ALHC's 0.75, lower leverage
- +24.2% vs MOH's -39.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.1% revenue growth vs CVS's 7.8% | |
| Value | Lower P/E (15.7x vs 19.9x) | |
| Quality / Margins | Combined ratio 1.0 vs CNC's 1.0 (lower = better underwriting) | |
| Stability / Safety | Beta 0.05 vs ALHC's 0.75, lower leverage | |
| Dividends | 2.4% yield, 25-year raise streak, vs CVS's 3.3%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +24.2% vs MOH's -39.9% | |
| Efficiency (ROA) | 3.9% ROA vs CNC's -7.9%, ROIC 9.2% vs -21.6% |
MOH vs CNC vs ALHC vs UNH vs CVS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MOH vs CNC vs ALHC vs UNH vs CVS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CNC leads in 1 of 6 categories
UNH leads 1 • MOH leads 0 • ALHC leads 0 • CVS leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — ALHC and UNH each lead in 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 105.6x ALHC's $4.3B. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to CNC's -3.3%. On growth, ALHC holds the edge at +33.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $45.1B | $198.1B | $4.3B | $449.7B | $402.1B |
| EBITDAEarnings before interest/tax | $710M | -$5.9B | $66M | $23.2B | $9.3B |
| Net IncomeAfter-tax profit | $188M | -$6.4B | $20M | $12.0B | $1.8B |
| Free Cash FlowCash after capex | $251M | $6.3B | $237M | $19.7B | $7.8B |
| Gross MarginGross profit ÷ Revenue | +9.6% | +14.9% | +9.0% | +18.8% | +13.8% |
| Operating MarginEBIT ÷ Revenue | +1.2% | -3.7% | +0.8% | +4.2% | +1.2% |
| Net MarginNet income ÷ Revenue | +0.4% | -3.3% | +0.5% | +2.7% | +0.4% |
| FCF MarginFCF ÷ Revenue | +0.6% | +3.2% | +5.6% | +4.4% | +1.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.1% | +7.1% | +33.3% | +2.0% | +8.2% |
| EPS Growth (YoY)Latest quarter vs prior year | -95.0% | +18.3% | +2.1% | +0.7% | +76.9% |
Valuation Metrics
CNC leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 21.5x trailing earnings, MOH trades at a 63% valuation discount to CVS's 58.1x P/E. On an enterprise value basis, MOH's 10.0x EV/EBITDA is more attractive than ALHC's 77.3x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $10.0B | $26.2B | $3.7B | $330.3B | $102.6B |
| Enterprise ValueMkt cap + debt − cash | $9.7B | $27.0B | $3.5B | $384.3B | $187.6B |
| Trailing P/EPrice ÷ TTM EPS | 21.54x | -3.89x | -4945.95x | 27.50x | 58.05x |
| Forward P/EPrice ÷ next-FY EPS est. | 37.27x | 15.70x | 141.31x | 19.87x | 11.27x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 9.95x | — | 77.35x | 16.48x | 12.52x |
| Price / SalesMarket cap ÷ Revenue | 0.22x | 0.13x | 0.95x | 0.74x | 0.26x |
| Price / BookPrice ÷ Book value/share | 2.40x | 1.30x | 20.21x | 3.26x | 1.36x |
| Price / FCFMarket cap ÷ FCF | — | 6.05x | 33.04x | 20.55x | 13.14x |
Profitability & Efficiency
UNH leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
UNH delivers a 11.5% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-29 for CNC. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to ALHC's 1.89x. On the Piotroski fundamental quality scale (0–9), CNC scores 6/9 vs MOH's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +4.4% | -28.6% | +11.5% | +11.5% | +2.3% |
| ROA (TTM)Return on assets | +1.2% | -7.9% | +1.8% | +3.9% | +0.7% |
| ROICReturn on invested capital | +17.4% | -21.6% | — | +9.2% | +5.0% |
| ROCEReturn on capital employed | +9.8% | -14.6% | +2.9% | +9.7% | +6.1% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.97x | 0.94x | 1.89x | 0.77x | 1.24x |
| Net DebtTotal debt minus cash | -$298M | $889M | -$240M | $54.0B | $85.1B |
| Cash & Equiv.Liquid assets | $4.2B | $17.9B | $578M | $24.4B | $8.5B |
| Total DebtShort + long-term debt | $4.0B | $18.8B | $338M | $78.4B | $93.6B |
| Interest CoverageEBIT ÷ Interest expense | 2.12x | -9.03x | 1.27x | 4.71x | 1.68x |
Total Returns (Dividends Reinvested)
Evenly matched — ALHC and CVS each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVS five years ago would be worth $11,195 today (with dividends reinvested), compared to $6,806 for ALHC. Over the past 12 months, CVS leads with a +24.2% total return vs MOH's -39.9%. The 3-year compound annual growth rate (CAGR) favors ALHC at 38.5% vs MOH's -13.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +7.7% | +26.8% | -9.5% | +8.8% | +2.4% |
| 1-Year ReturnPast 12 months | -39.9% | -11.4% | +18.2% | -7.9% | +24.2% |
| 3-Year ReturnCumulative with dividends | -35.8% | -22.6% | +165.6% | -21.4% | +25.3% |
| 5-Year ReturnCumulative with dividends | -26.9% | -18.9% | -31.9% | -2.8% | +11.9% |
| 10-Year ReturnCumulative with dividends | +323.6% | +74.6% | +5.7% | +217.0% | -2.2% |
| CAGR (3Y)Annualised 3-year return | -13.8% | -8.2% | +38.5% | -7.7% | +7.8% |
Risk & Volatility
Evenly matched — MOH and CVS each lead in 1 of 2 comparable metrics.
Risk & Volatility
MOH is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than ALHC's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 94.8% from its 52-week high vs MOH's 57.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.04x | 0.39x | 0.75x | 0.59x | 0.05x |
| 52-Week HighHighest price in past year | $333.00 | $64.15 | $23.87 | $409.70 | $85.15 |
| 52-Week LowLowest price in past year | $121.06 | $25.08 | $11.63 | $234.60 | $58.35 |
| % of 52W HighCurrent price vs 52-week peak | +57.7% | +82.6% | +76.7% | +88.8% | +94.8% |
| RSI (14)Momentum oscillator 0–100 | 79.6 | 83.9 | 42.6 | 83.3 | 62.0 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 5.7M | 3.6M | 8.1M | 7.3M |
Analyst Outlook
Evenly matched — UNH and CVS each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MOH as "Buy", CNC as "Buy", ALHC as "Buy", UNH as "Buy", CVS as "Buy". Consensus price targets imply 35.7% upside for ALHC (target: $25) vs -13.6% for MOH (target: $166). For income investors, CVS offers the higher dividend yield at 3.31% vs UNH's 2.39%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $166.09 | $51.00 | $24.83 | $385.43 | $95.20 |
| # AnalystsCovering analysts | 38 | 43 | 16 | 52 | 41 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +2.4% | +3.3% |
| Dividend StreakConsecutive years of raises | — | 1 | — | 25 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | $8.70 | $2.67 |
| Buyback YieldShare repurchases ÷ mkt cap | +10.0% | +1.8% | 0.0% | +1.7% | 0.0% |
CNC leads in 1 of 6 categories (Valuation Metrics). UNH leads in 1 (Profitability & Efficiency). 4 tied.
MOH vs CNC vs ALHC vs UNH vs CVS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MOH or CNC or ALHC or UNH or CVS a better buy right now?
For growth investors, Alignment Healthcare, Inc.
(ALHC) is the stronger pick with 46. 1% revenue growth year-over-year, versus 7. 8% for CVS Health Corporation (CVS). Molina Healthcare, Inc. (MOH) offers the better valuation at 21. 5x trailing P/E (37. 3x forward), making it the more compelling value choice. Analysts rate Molina Healthcare, Inc. (MOH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MOH or CNC or ALHC or UNH or CVS?
On trailing P/E, Molina Healthcare, Inc.
(MOH) is the cheapest at 21. 5x versus CVS Health Corporation at 58. 1x. On forward P/E, CVS Health Corporation is actually cheaper at 11. 3x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — MOH or CNC or ALHC or UNH or CVS?
Over the past 5 years, CVS Health Corporation (CVS) delivered a total return of +11.
9%, compared to -31. 9% for Alignment Healthcare, Inc. (ALHC). Over 10 years, the gap is even starker: MOH returned +323. 6% versus CVS's -2. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MOH or CNC or ALHC or UNH or CVS?
By beta (market sensitivity over 5 years), Molina Healthcare, Inc.
(MOH) is the lower-risk stock at -0. 04β versus Alignment Healthcare, Inc. 's 0. 75β — meaning ALHC is approximately -2145% more volatile than MOH relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 189% for Alignment Healthcare, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MOH or CNC or ALHC or UNH or CVS?
By revenue growth (latest reported year), Alignment Healthcare, Inc.
(ALHC) is pulling ahead at 46. 1% versus 7. 8% for CVS Health Corporation (CVS). On earnings-per-share growth, the picture is similar: Alignment Healthcare, Inc. grew EPS 99. 4% year-over-year, compared to -315. 8% for Centene Corporation. Over a 3-year CAGR, ALHC leads at 40. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MOH or CNC or ALHC or UNH or CVS?
UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.
7% net margin versus -3. 4% for Centene Corporation — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -3. 9% for CNC. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MOH or CNC or ALHC or UNH or CVS more undervalued right now?
On forward earnings alone, CVS Health Corporation (CVS) trades at 11.
3x forward P/E versus 141. 3x for Alignment Healthcare, Inc. — 130. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALHC: 35. 7% to $24. 83.
08Which pays a better dividend — MOH or CNC or ALHC or UNH or CVS?
In this comparison, CVS (3.
3% yield), UNH (2. 4% yield) pay a dividend. MOH, CNC, ALHC do not pay a meaningful dividend and should not be held primarily for income.
09Is MOH or CNC or ALHC or UNH or CVS better for a retirement portfolio?
For long-horizon retirement investors, CVS Health Corporation (CVS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
05), 3. 3% yield). Both have compounded well over 10 years (CVS: -2. 2%, ALHC: +5. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MOH and CNC and ALHC and UNH and CVS?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MOH is a mid-cap quality compounder stock; CNC is a mid-cap high-growth stock; ALHC is a small-cap high-growth stock; UNH is a large-cap quality compounder stock; CVS is a mid-cap income-oriented stock. UNH, CVS pay a dividend while MOH, CNC, ALHC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.